{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T02:40:45Z","timestamp":1648694445434},"reference-count":43,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental Parasitology"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.exppara.2011.09.014","type":"journal-article","created":{"date-parts":[[2011,10,16]],"date-time":"2011-10-16T08:01:43Z","timestamp":1318752103000},"page":"58-62","source":"Crossref","is-referenced-by-count":4,"title":["Evidence of intra-hepatic vascular proliferation remodeling early after cure in experimental schistosomiasis mansoni: An immunohistochemical descriptive study"],"prefix":"10.1016","volume":"130","author":[{"given":"Nashwa S.","family":"Abdel Fattah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naglaa S.","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.exppara.2011.09.014_b0005","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1023\/A:1018863718430","article-title":"Serum vascular endothelial growth factor levels in various liver diseases","volume":"43","author":"Akiyoshi","year":"1998","journal-title":"Dig. Dis. Sci."},{"issue":"4","key":"10.1016\/j.exppara.2011.09.014_b0015","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1590\/S0074-02762010000400013","article-title":"Angiogenesis and schistosomiasis","volume":"105","author":"Andrade","year":"2010","journal-title":"Mem. Inst. Oswaldo Cruz"},{"issue":"Suppl. I","key":"10.1016\/j.exppara.2011.09.014_b0010","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1590\/S0074-02762006000900041","article-title":"Remodeling of hepatic vascular changes after specific chemotherapy of schistosomal periportal fibrosis","volume":"101","author":"Andrade","year":"2006","journal-title":"Mem. Inst. Oswaldo Cruz."},{"key":"10.1016\/j.exppara.2011.09.014_b0020","doi-asserted-by":"crossref","first-page":"G245","DOI":"10.1152\/ajpgi.2000.279.2.G245","article-title":"Fibrogenesis II. Metalloproteinases and their inhibitors in liver fibrosis","volume":"279","author":"Arthur","year":"2000","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.exppara.2011.09.014_b0025","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1159\/000101796","article-title":"Contribution of the endothelium to the glomerular permselectivity barrier in health and disease","volume":"106","author":"Ballermann","year":"2007","journal-title":"Nephron. Physiol."},{"key":"10.1016\/j.exppara.2011.09.014_b0030","first-page":"713","article-title":"Hemodynamics and antifibrotic effects of losartan in rats with liver fibrosis and portal hypertension","volume":"37","author":"Croquet","year":"2003","journal-title":"J. Hepatol."},{"issue":"6","key":"10.1016\/j.exppara.2011.09.014_b0035","doi-asserted-by":"crossref","first-page":"e11256","DOI":"10.1371\/journal.pone.0011256","article-title":"Broad-spectrum matrix metalloproteinase inhibition curbs inflammation and liver injury but aggravates experimental liver fibrosis in mice","volume":"5","author":"de Meijer","year":"2010","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.exppara.2011.09.014_b0040","first-page":"219","article-title":"Experimental evaluation of propolis-a natural bee product in Schistosoma mansoni infection","volume":"20","author":"El-Hoseiny","year":"1999","journal-title":"Egy. J. Med. Sci."},{"key":"10.1016\/j.exppara.2011.09.014_b0045","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.cld.2006.08.022","article-title":"Reversal of fibrosis: no longer a pipe dream?","volume":"10","author":"Fallowfield","year":"2006","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/j.exppara.2011.09.014_b0050","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1002\/hep.21785","article-title":"Reversal of portal hypertension and hyperdynamic splanchnic circulation by combined vascular endothelial growth factor and platelet-derived growth factor blockade in rats","volume":"46","author":"Fernandez","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.exppara.2011.09.014_b0055","first-page":"1","article-title":"Angiogenesis and angiogenesis inhibition: an overview","volume":"79","author":"Folkman","year":"1997","journal-title":"EXS"},{"key":"10.1016\/j.exppara.2011.09.014_b0060","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1152\/physrev.00013.2007","article-title":"Hepatic stellate cells: protean, multifunctional and enigmatic cells of the liver","volume":"88","author":"Friedman","year":"2008","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.exppara.2011.09.014_b0065","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1053\/j.gastro.2008.03.003","article-title":"Mechanisms of hepatic fibrogenesis","volume":"134","author":"Friedman","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.exppara.2011.09.014_b0070","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1023\/A:1026618904493","article-title":"Vascular endothelial growth factor levels in liver cirrhosis","volume":"44","author":"Genesca","year":"1999","journal-title":"Dig. Dis. Sci."},{"issue":"6","key":"10.1016\/j.exppara.2011.09.014_b0075","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1586\/17474124.2.6.803","article-title":"Advances in anti-fibrotic therapy","volume":"2","author":"Ghiassi-Nejad","year":"2008","journal-title":"Expert. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.exppara.2011.09.014_b0080","first-page":"187","article-title":"Angiogenic factor expression in hepatic cirrhosis","volume":"67","author":"Giatromanolaki","year":"2007","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.exppara.2011.09.014_b0085","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1056\/NEJMra035021","article-title":"Management of cirrhosis and ascites","volume":"350","author":"Gines","year":"2004","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.exppara.2011.09.014_b0090","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/MOG.0b013e3283279668","article-title":"Hepatic fibrosis","volume":"25","author":"Jiao","year":"2009","journal-title":"Curr. Opin. Gastroenterol."},{"key":"10.1016\/j.exppara.2011.09.014_b0095","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1681\/ASN.V1271448","article-title":"Impaired angiogenesis in the remnant kidney model: II. Vascular endothelial growth factor administration reduces renal fibrosis and stabilizes renal function","volume":"12","author":"Kang","year":"2001","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.exppara.2011.09.014_b0100","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1681\/ASN.V1271434","article-title":"Impaired angiogenesis in the remnant kidney model: I. Potential role of vascular endothelial growth factor and thrombospondin-1","volume":"12","author":"Kang","year":"2001","journal-title":"J. Am. Soc. Nephrol."},{"issue":"1","key":"10.1016\/j.exppara.2011.09.014_b0105","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.molbiopara.2005.08.001","article-title":"Characterisation and partial purification of Schistosoma mansoni egg-derived pro-angiogenic factor","volume":"144","author":"Kanse","year":"2005","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.exppara.2011.09.014_b0110","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1002\/hep.21338","article-title":"Leptin-mediated neovascularization is a prerequisite for progression of nonalcoholic steatohepatitis in rats","volume":"44","author":"Kitade","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.exppara.2011.09.014_b0115","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jhep.2004.11.008","article-title":"Angiogenesis and chronic inflammation; the potential for novel therapeutic approaches in chronic liver disease","volume":"42","author":"Lai","year":"2005","journal-title":"J. Hepatol."},{"key":"10.1016\/j.exppara.2011.09.014_b0120","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1590\/S0074-02762007005000115","article-title":"Thalidomide failed to inhibit angiogenesis and fibrosis in hepatic schistosomiasis of the mouse","volume":"102","author":"Lima","year":"2007","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.exppara.2011.09.014_b0125","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1086\/340416","article-title":"Soluble egg antigens from Schistosoma mansoni induce angiogenesis-related processes by up-regulating vascular endothelial growth factor in human endothelial cells","volume":"185","author":"Loeffler","year":"2002","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.exppara.2011.09.014_b0130","first-page":"907","article-title":"Vascular endothelial growth factor level in chronic liver diseases","volume":"32","author":"Makhlouf","year":"2002","journal-title":"J. Egypt. Soc. Parasitol."},{"key":"10.1016\/j.exppara.2011.09.014_b0135","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jhep.2004.09.024","article-title":"Evidence of angiogenesis in primary biliary cirrhosis: an immunohistochemical descriptive study","volume":"42","author":"Medina","year":"2005","journal-title":"J. Hepatol."},{"key":"10.1016\/j.exppara.2011.09.014_b0140","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/labinvest.3700436","article-title":"Permeability properties of tumor surrogate blood vessels induced by VEGF-A","volume":"86","author":"Nagy","year":"2006","journal-title":"Lab. Invest."},{"issue":"3","key":"10.1016\/j.exppara.2011.09.014_b0145","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3748\/wjg.v16.i3.281","article-title":"Hypoxia, angiogenesis and liver fibrogenesis in the progression of chronic liver diseases","volume":"16","author":"Paternostro","year":"2010","journal-title":"World J. Gastroenterol."},{"issue":"5","key":"10.1016\/j.exppara.2011.09.014_b0150","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1002\/hep.23144","article-title":"Pharmacological inhibition of Integrin AlphaV Beta3 Aggravates experimental liver fibrosis and suppresses hepatic angiogenesis","volume":"50","author":"Patsenker","year":"2009","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.exppara.2011.09.014_b0155","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.cld.2008.07.011","article-title":"Current and future anti-fibrotic therapies for chronic liver disease","volume":"12","author":"Rocky","year":"2008","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/j.exppara.2011.09.014_b0160","doi-asserted-by":"crossref","first-page":"312","DOI":"10.3748\/wjg.v9.i2.312","article-title":"Angiogenesis effect on rat liver after administration of expression vector encoding vascular endothelial growth factor D","volume":"9","author":"Shi","year":"2003","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.exppara.2011.09.014_b0165","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.prp.2006.07.004","article-title":"Pathogenesis of septal fibrosis of the liver (an experimental study with a new model)","volume":"202","author":"Souza","year":"2006","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.exppara.2011.09.014_b0170","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.hepres.2006.01.010","article-title":"Significance and fate of septal fibrosis of the liver","volume":"35","author":"Souza","year":"2006","journal-title":"Hepatol. Res."},{"key":"10.1016\/j.exppara.2011.09.014_b0175","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1053\/j.gastro.2008.07.065","article-title":"Hepatic stellate cells secrete angiopoietin 1 that induces angiogenesis in liver fibrosis","volume":"135","author":"Taura","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.exppara.2011.09.014_b0180","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1002\/hep.21921","article-title":"Antiangiogenic treatment with sunitinib ameliorates inflammatory infiltrate, fibrosis, and portal pressure in cirrhotic rats","volume":"46","author":"Tugues","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.exppara.2011.09.014_b0185","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1097\/00001432-200410000-00009","article-title":"Morbidity in schistosomiasis: an update","volume":"17","author":"Vennervald","year":"2004","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.exppara.2011.09.014_b0190","first-page":"657","article-title":"Public health impact of schistosomiasis: disease and mortality. WHO expert. Committee on the control of schistosomiasis","volume":"71","author":"WHO","year":"1993","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.exppara.2011.09.014_b0195","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/path.2277","article-title":"Cellular and molecular mechanisms of fibrosis","volume":"214","author":"Wynn","year":"2008","journal-title":"J. Pathol."},{"issue":"15","key":"10.1016\/j.exppara.2011.09.014_b0200","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.3748\/wjg.14.2349","article-title":"Vascular endothelial growth factor attenuates hepatic sinusoidal capillarization in thioacetamide-induced cirrhotic rats","volume":"14","author":"Xu","year":"2008","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.exppara.2011.09.014_b0205","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1478-3231.2003.00880.x","article-title":"Vascular endothelial growth factor increases fenestral permeability in hepatic sinusoidal endothelial cells","volume":"23","author":"Yokomori","year":"2003","journal-title":"Liver Int."},{"key":"10.1016\/j.exppara.2011.09.014_b0210","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1159\/000069792","article-title":"Angiotensin-I-converting enzyme inhibitors may be an alternative anti-angiogenic strategy in the treatment of liver fibrosis and hepatocellular carcinoma. Possible role of vascular endothelial growth factor","volume":"23","author":"Yoshiji","year":"2002","journal-title":"Tumour Biol."},{"key":"10.1016\/j.exppara.2011.09.014_b0215","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1136\/gut.52.9.1347","article-title":"Vascular endothelial growth factor and receptor interaction is a prerequisite for murine hepatic fibrogenesis","volume":"52","author":"Yoshiji","year":"2003","journal-title":"Gut"}],"container-title":["Experimental Parasitology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014489411002992?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014489411002992?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,12,11]],"date-time":"2021-12-11T04:29:20Z","timestamp":1639196960000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014489411002992"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S0014489411002992"],"URL":"https:\/\/doi.org\/10.1016\/j.exppara.2011.09.014","relation":{},"ISSN":["0014-4894"],"issn-type":[{"value":"0014-4894","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}